Patent · US Expired

1,4 substituted piperidinyl NMDA/NR2B antagonists

US6476041B1 · kind B1 · utility

8Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2000
Grant dateNov 5, 2002
Priority date—
Expiry dateOct 25, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel piperidinyl compounds substituted in the 1- and 4-positions are effective as NMDA NR2B antagonists useful for relieving pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.